GLPwatch
Vision changes / NAION
5,283 FAERS reports across 10 drugs
Last updated 2026-05-28 15:46 UTCVision changes that happen suddenly and can include blurry or dim vision, or even partial loss of sight in one eye.
Plain-language definition of the term.
The FDA labels for Soliqua and Xultophy include 'Vision changes / NAION' in their Dosage and Administration sections, indicating a mention of this potential adverse effect.
AI summary of the sources below.
FAERS report counts (as of 2026Q1) reflect voluntary adverse-event reports and cannot establish causation or true frequency; higher counts often track prescription volume. openFDA FAERS ↗
Reports by drug
| Drug | FAERS reports | Quarter |
|---|---|---|
| Ozempic | 1,494 | 2026Q1 |
| Trulicity | 1,371 | 2026Q1 |
| Mounjaro | 765 | 2026Q1 |
| Bydureon | 450 | 2026Q1 |
| Victoza | 373 | 2026Q1 |
| Wegovy | 341 | 2026Q1 |
| Zepbound | 247 | 2026Q1 |
| Soliqua | 143 | 2026Q1 |
| Rybelsus | 88 | 2026Q1 |
| Xultophy | 11 | 2026Q1 |